Shares of West Pharmaceutical Services Inc. WST rallied 3.56% to $210.91 Friday, on what proved to be an all-around poor ...

West Pharmaceutical Services Inc. closed 47.37% below its 52-week high of $400.88, which the company reached on March 21st.

NEW YORK, NY / ACCESS Newswire / February 21, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West ...

We recently published a list of These Were Last Week’s 10 Worst Performers. In this article, we are going to take a look at ...

What Happened? Shares of healthcare products company West Pharmaceutical Services (NYSE:WST) fell 34.9% in the afternoon ...

West Pharmaceutical’s earnings results led to a 38% drop. Find out why WST stock could be worth watching for future rebounds ...

However, its future guidance fell short of market expectations, leading to a decline in its stock price after the announcement. Separately, with uncertainty surrounding the company, see What’s Next ...

CIBC Asset Management Inc raised its position in shares of West Pharmaceutical Services, Inc. (NYSE:WST – Free Report) by 4.5% in the fourth quarter, HoldingsChannel reports. The firm owned 11,058 ...

West Pharmaceutical Services, Inc. (NYSE:WST) reported a fourth-quarter adjusted EPS of $1.82, beating the consensus of $1.72 ...

West Pharmaceutical Services stock sank Thursday after the company issued a full-year outlook that missed analysts’ expectations. Shares plunged 31% to $222.46, putting them on pace for their worst ...

West Pharmaceutical Services (NYSE:WST – Get Free Report) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a research report issued to clients and ...

In its fourth quarter 2024 investor letter, Conestoga Capital Advisors emphasized stocks such as West Pharmaceutical Services ...